ANITA EFFINGER: Open Payments
NPI 1578923314 · SOUTHFIELD, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,074 in 55 payments from 23 companies in 2025. Trend: 2023 $1,152 · 2024 $1,303 · 2025 $1,074
Food & beverage: $1,074
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $230 |
| Novo Nordisk Inc | 10 | $181 |
| Indivior Inc. | 4 | $76 |
| Boston Scientific Corporation | 2 | $50 |
| Orexo US, Inc. | 2 | $49 |
| GlaxoSmithKline, LLC. | 2 | $40 |
| Exact Sciences Corporation | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| IRONWOOD PHARMACEUTICALS, INC | 2 | $36 |
| Aimmune Therapeutics, Inc. | 2 | $36 |
Products named: VRAYLAR, Wegovy, SUBLOCADE, Rybelsus, LINZESS, WATCHMAN FLX, Zubsolv, MAVYRET.
Industry payments across MI — which companies pay providers there.
